Read article – Quotes Christine Cooley MED ’06, in an article about the new state-of-the-art 3D mammography—a cutting-edge imaging technology that affords healthcare providers a more accurate view of tissue, compared to the conventional two-dimensional mammograms, which result in a higher incidence of false positives. “If the patient has really dense breast tissue, there are things that can be hiding,” says Cooley. “With this new technology, I can find a little cancer inside that breast. With the older technology, I probably wouldn’t have seen that cancer for another year or two until it got bigger.”

Read article – A profile of Charles Brummer, MED ’81, who is retiring at the end of November after 35 years of practicing medicine in Massachusetts’ Pioneer Valley.

Read article – Dartmouth and a healthcare technology company called Q2i are sharing $4.7 million in federal grant money to work on improving the treatment of opioid addiction. The funding is from the National Institutes of Health for a program that provides resources to test new approaches aimed at improving treatment for chronic pain, curbing the rates of opioid use disorder and overdoses, and achieving long-term recovery from opioid addiction. (Picked up by WMUR, NBC 5, WCAX, and Charlotte Observer. Similar coverage in New Hampshire Union Leader.)

Listen to story – Continued coverage of comments by Bruce Vrooman, associate professor of anesthesiology, about treating patients with complex chronic pain, and how for some patients, low-dose naltrexone appears to be more effective and well-tolerated than the big-name opioids that dominated pain management for decades. (Picked up by Yahoo! Lifestyle and Pain News Network.)

Read article – TREAT, the Lebanon-based Center for the Translation of Rehabilitation Engineering Advances in Technology, has been awarded a $50,000 grant in the U.S. Small Business Administration’s Growth Accelerator Fund Competition. TREAT is a consortium that includes Dartmouth’s Geisel School of Medicine and Tuck School of Business and Celdara Medical, a biotech firm based in Lebanon, among several others.

Read article – Continued coverage of comments by Bruce Vrooman, associate professor of anesthesiology, about treating patients with complex chronic pain, and how for some patients, low-dose naltrexone appears to be more effective and well-tolerated than the big-name opioids that dominated pain management for decades.

Read article – Features an interview with David Whitehouse, MED ’82, medical director of the virtual behavioral health services provider AbleTo, in which he discusses the potential and best practices for providing behavioral health services through telemedicine.

Read article – Quotes James Sargent, the Scott M. and Lisa G. Stuart Professor, in an article reporting about how California health officials issued a warning Tuesday urging people to stop vaping immediately, joining a growing chorus of health experts advising caution around e-cigarette use following recent reports of severe lung illnesses linked to the practice.

Listen to story – Continued coverage of comments by Bruce Vrooman, associate professor of anesthesiology, about treating patients with complex chronic pain, and how for some patients, low-dose naltrexone appears to be more effective and well-tolerated than the big-name opioids that dominated pain management for decades. “Those patients may report that this is indeed a game-changer,” Vrooman says. “It may truly help them with their activities, help them feel better.”

Read article – Quotes John Nigriny, assistant professor of surgery, about a study he led that found that U.S. plastic surgeons who developed a telehealth workflow had more time with patients for real-time clinical decision-making, saved patients and doctors time, and significantly reduced costs.